Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Herbert Pang

Showing results (61-70 of 109) with videos related to

Pageof 11
Sort By:
International Journal of Epidemiology|December 25, 2019
Determinants of physical, mental and social well-being: a longitudinal environment-wide association studyMichael Y Ni, Xiaoxin I Yao, Felix Cheung, et al.
British Journal of Cancer|May 27, 2020
Endpoint surrogacy in oncology Phase 3 randomised controlled trialsJianrong Zhang, Meagan R Pilar, Xiaofei Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|January 8, 2014
Predictors of pulmonary toxicity in limited stage small cell lung cancer patients treated with induction chemotherapy followed by concurrent platinum-based chemotherapy and 70 Gy daily radiotherapy: CALGB 30904Joseph K Salama, Herbert Pang, Jeffrey A Bogart, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 23, 2015
Normative data and psychometric properties of the Connor-Davidson Resilience Scale (CD-RISC) and the abbreviated version (CD-RISC2) among the general population in Hong KongMichael Y Ni, Tom K Li, Nancy X Yu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 21, 2010
A phase II study of dasatinib in patients with chemosensitive relapsed small cell lung cancer (Cancer and Leukemia Group B 30602)Antonius A Miller, Herbert Pang, Lydia Hodgson, et al.
Clinical Colorectal Cancer|August 23, 2011
A phase II study of oxaliplatin, dose-intense capecitabine, and high-dose bevacizumab in the treatment of metastatic colorectal cancerNan Soon Wong, Nishan H Fernando, Johanna C Bendell, et al.
Pharmaceutical Statistics|September 25, 2023
Evaluating hybrid controls methodology in early-phase oncology trials: A simulation study based on the MORPHEUS-UC trialGuanbo Wang, Melanie Poulin-Costello, Herbert Pang, et al.
Cancer Medicine|May 2, 2013
Correlation of angiogenic biomarker signatures with clinical outcomes in metastatic colorectal cancer patients receiving capecitabine, oxaliplatin, and bevacizumabYingmiao Liu, Mark D Starr, Anuradha Bulusu, et al.
American Journal of Public Health|February 17, 2017
Longitudinal Patterns and Predictors of Depression Trajectories Related to the 2014 Occupy Central/Umbrella Movement in Hong KongMichael Y Ni, Tom K Li, Herbert Pang, et al.
Cancer Epidemiology|August 5, 2019
Reporting and guidelines for mendelian randomization analysis: A systematic review of oncological studiesGary C Y Lor, Harvey A Risch, W T Fung, et al.
Pageof 11

Showing results (61-70 of 109) with videos related to

Sort By:
Pageof 11
International Journal of Epidemiology|December 25, 2019
Determinants of physical, mental and social well-being: a longitudinal environment-wide association studyMichael Y Ni, Xiaoxin I Yao, Felix Cheung, et al.
British Journal of Cancer|May 27, 2020
Endpoint surrogacy in oncology Phase 3 randomised controlled trialsJianrong Zhang, Meagan R Pilar, Xiaofei Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|January 8, 2014
Predictors of pulmonary toxicity in limited stage small cell lung cancer patients treated with induction chemotherapy followed by concurrent platinum-based chemotherapy and 70 Gy daily radiotherapy: CALGB 30904Joseph K Salama, Herbert Pang, Jeffrey A Bogart, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 23, 2015
Normative data and psychometric properties of the Connor-Davidson Resilience Scale (CD-RISC) and the abbreviated version (CD-RISC2) among the general population in Hong KongMichael Y Ni, Tom K Li, Nancy X Yu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 21, 2010
A phase II study of dasatinib in patients with chemosensitive relapsed small cell lung cancer (Cancer and Leukemia Group B 30602)Antonius A Miller, Herbert Pang, Lydia Hodgson, et al.
Clinical Colorectal Cancer|August 23, 2011
A phase II study of oxaliplatin, dose-intense capecitabine, and high-dose bevacizumab in the treatment of metastatic colorectal cancerNan Soon Wong, Nishan H Fernando, Johanna C Bendell, et al.
Pharmaceutical Statistics|September 25, 2023
Evaluating hybrid controls methodology in early-phase oncology trials: A simulation study based on the MORPHEUS-UC trialGuanbo Wang, Melanie Poulin-Costello, Herbert Pang, et al.
Cancer Medicine|May 2, 2013
Correlation of angiogenic biomarker signatures with clinical outcomes in metastatic colorectal cancer patients receiving capecitabine, oxaliplatin, and bevacizumabYingmiao Liu, Mark D Starr, Anuradha Bulusu, et al.
American Journal of Public Health|February 17, 2017
Longitudinal Patterns and Predictors of Depression Trajectories Related to the 2014 Occupy Central/Umbrella Movement in Hong KongMichael Y Ni, Tom K Li, Herbert Pang, et al.
Cancer Epidemiology|August 5, 2019
Reporting and guidelines for mendelian randomization analysis: A systematic review of oncological studiesGary C Y Lor, Harvey A Risch, W T Fung, et al.
Pageof 11